Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
466
Zitationen
21
Autoren
2020
Jahr
Abstract
Alzheimer's disease is the primary cause of dementia worldwide, with an increasing morbidity burden that may outstrip diagnosis and management capacity as the population ages. Current methods integrate patient history, neuropsychological testing and MRI to identify likely cases, yet effective practices remain variably applied and lacking in sensitivity and specificity. Here we report an interpretable deep learning strategy that delineates unique Alzheimer's disease signatures from multimodal inputs of MRI, age, gender, and Mini-Mental State Examination score. Our framework linked a fully convolutional network, which constructs high resolution maps of disease probability from local brain structure to a multilayer perceptron and generates precise, intuitive visualization of individual Alzheimer's disease risk en route to accurate diagnosis. The model was trained using clinically diagnosed Alzheimer's disease and cognitively normal subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset (n = 417) and validated on three independent cohorts: the Australian Imaging, Biomarker and Lifestyle Flagship Study of Ageing (AIBL) (n = 382), the Framingham Heart Study (n = 102), and the National Alzheimer's Coordinating Center (NACC) (n = 582). Performance of the model that used the multimodal inputs was consistent across datasets, with mean area under curve values of 0.996, 0.974, 0.876 and 0.954 for the ADNI study, AIBL, Framingham Heart Study and NACC datasets, respectively. Moreover, our approach exceeded the diagnostic performance of a multi-institutional team of practicing neurologists (n = 11), and high-risk cerebral regions predicted by the model closely tracked post-mortem histopathological findings. This framework provides a clinically adaptable strategy for using routinely available imaging techniques such as MRI to generate nuanced neuroimaging signatures for Alzheimer's disease diagnosis, as well as a generalizable approach for linking deep learning to pathophysiological processes in human disease.
Ähnliche Arbeiten
"Why Should I Trust You?"
2016 · 14.785 Zit.
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
2005 · 10.554 Zit.
A Comprehensive Survey on Graph Neural Networks
2020 · 8.982 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.591 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 8.114 Zit.
Autoren
Institutionen
- Boston University(US)
- Framingham Heart Study(US)
- Georgia Institute of Technology(US)
- Chinese Academy of Medical Sciences & Peking Union Medical College(CN)
- Peking Union Medical College Hospital(CN)
- Texas Tech University(US)
- The University of Texas Health Science Center at Houston(US)
- Texas Tech University Health Sciences Center(US)
- University of Nebraska Medical Center(US)